WCN24-1774 eGFR DECLINE IN PATIENTS WITH IgAN TREATED WITH NEFECON OR PLACEBO: RESULTS FROM THE 2-YEAR NefIgArd PHASE 3 TRIAL - Richard Lafayette; Jens Kristensen; Andrew Stone; Jürgen Floege; Vladimír Tesař; Hernán Trimarchi; Hong Zhang; Necmi Eren; Alexander Paliege; Heather N. Reich; Brad H. Rovin; Jonathan Barratt (Kidney International Reports)